Drug profile · INN
elosulfase alfa
VIMIZIM
- US status
- approved
- Patents linked
- 0
- News articles
- 0
Quick answer
elosulfase alfa (VIMIZIM) is an FDA-listed pharmaceutical active ingredient. Associated with BioMarin International Limited. Route of administration: injection. Current US regulatory status: approved.
Key facts
INN elosulfase alfa
Brand VIMIZIM
Route INJECTION
Formulation INJECTABLE
ATC code A16AB12
Originator BioMarin International Limited
Frequently asked questions
What is elosulfase alfa?
elosulfase alfa (VIMIZIM) is an FDA-listed pharmaceutical active ingredient. Associated with BioMarin International Limited. Route of administration: injection. Current US regulatory status: approved.
What is the brand name for elosulfase alfa?
VIMIZIM is a marketed brand name for elosulfase alfa. Check FDA Drugs@FDA for the current US label holder and prescribing information.
What is the US approval status of elosulfase alfa?
elosulfase alfa has approved status in the United States according to our Drugs@FDA-derived records. Verify on the official FDA label before clinical or commercial decisions.